The medical utility of genomics data in neuropsychiatry: Mutational genetics versus association genetics

Current Opinion in Biotechnology

Volumn 8, Issue 6, 1997, Pages 688-691

  Peroutka, Stephen J ^a  

^a Spectra Biomedical Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENETIC DISORDER; GENETIC VARIABILITY; GENOME; HUMAN; NEUROPSYCHIATRY; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0030692743     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-1669(97)80120-6     Document Type: Article

References (38)

1. Cohen J. The genomics gamble. Science. 275:1997;767-772.
2. Risch N, Merikangas KR. Linkage studies of psychiatric disorders. Eur Arch Psychiatry Clin Neurosci. 243:1993;143-149.
3. Benjamin J, Li L, Patterson C, Greenberg BD, Murphy DL, Hamer DH. Population and familial association between the D4 dopamine receptor gene and measures of novelty seeking. Nat Genet. 12:1996;81-84.
4. Risch N, Botstein D. A manic depressive history. of outstanding interest Nat Genet. 12:1996;351-359 An objective critique of the failure of mutational genetics in the study of manic depression. The authors provide a summary of existing data and recommendations for future studies.
5. King M. Leaving Kansas...finding genes in 1997. Nat Genet. 15:1997;8-10.
6. Nothen MM, Propping P, Fimmers R. Association versus linkage studies in psychosis genetics. J Med Genet. 30:1992;634-637.
7. Greenberg DA. Linkage analysis of 'necessary' disease loci versus 'suspectibility' loci. Am J Hum Genet. 52:1993;135-143.
8. Risch N, Merikangas K. The future of genetic studies of complex human diseases. of outstanding interest Science. 273:1996;1516-1517 An excellent overview of the value of association genetics. Provides specific data on the sensitivity of various statistical approaches.
9. Peroutka SJ. Multiphenotypic allelic profiling: a novel strategy for functional genomics. Functional Genomics: Drug Discovery from Gene to Screen. 1997;1-15 International Business Communications, Southboroigh, Massachusetts.
10. Kannel WB. CHD risk factors: a Framingham study update. Hosp Pract. 25:1990;119-130.
11. Wilson PWF. Established risk factors and coronary artery disease: the Framingham study. Am J Hypertens. 7:1994;7S-12S.
12. Hancock EW. Coronary artery disease epidemiology and prevention. Dale DC, Federman DD. Scientific American Medicine. 1995;1-12 Scientific American, Inc. New York.
13. Comings DE, Wu S, Chiu C, Ring RH, Gade R, Ahn C, MacMurray JP, Dietz G, Muhleman D. Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: the additive and subtractive effect of the three dopaminergic genes - DRD2, DBH, and DAT1. Am J Hum Genet. 67:1996;264-288.
14. Blum K, Noble EP, Sheridan PJ, Montgomery A, Ritchie T, Jagadeeswaran P, Nogami H, Briggs AH, Cohn JH. Allelic assocation of human dopamine D2 receptor gene in alcoholism. JAMA. 263:1990;2055-2060.
15. Noble EP, Blum K, Ritchie T, Montgomery A, Sheridan PJ. Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Arch Gen Psychiatry. 48:1991;648-654.
16. Blum K, Noble EP, Sheridan RJ, Finley O, Montgomery A, Ritchie T, Ozkaragoz T, Fitch RJ, Sadlack F, Sheffield D, et al. Association of the A1 allele of the D2 dopamine receptor gene with severe alcoholism. Alcohol. 8:1991;409-416.
17. Comings DE, Comings BG, Muhleman D, Shahbahrami B, Tast D, Knell E, Koosis P, Baumgarten, Kovacs BW. The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders. JAMA. 266:1991;1793-1800.
18. Parsian A, Todd RD, Devor EJ, O'Malley KL, Suarez BK, Reich T, Cloninger CR. Alcoholism and alleles of the human D2 dopamine receptor locus. Arch Gen Psychiatry. 48:1991;655-663.
19. Amadeo S, Abbar M, Fourcade ML, Waksman G, Leroux MG, Madec A, Selin M, Champiat J, Brethome A, Leclaire Y, et al. D2 dopamine receptor gene and alcoholism. J Psychiat Res. 27:1993;173-179.
20. Blum K, Noble EP, Sheridan PJ, Montgomery A, Ritchie T, Ozkaragoz T, Fitch RJ, Wood R, Finley O, Sadlack F. Genetic predisposition in alcoholism: association of the D2 dopamine receptor Taql B1 RFLP with severe alcoholics. Alcohol. 10:1993;59-67.
21. Noble EP, Syndulko K, Fitch RJ, Ritchie T, Bohlman MC, Guth P, Sheriden A. D2 dopamine receptor Taql a alleles in medically ill alcoholic and nonalcoholic patients. Alc Alcohol. 29:1994;729-744.
22. Neiswanger K, Hill SY, Kaplan BB. Association and linkage studies of the TAQ1 A1 allele at the dopamine D2 receptor gene in samples of female and male alcoholics. Am J Med Gen. 60:1995;267-271.
23. Noble EP. The gene that rewards alchoholism. Sci Med. 3:1996;52-61.
24. Bolos AM, Dean M, Lucas-Derse S, Ramsburg M, Brown GL, Goldman D. Population and pedigree studies reveal a lack of association between the dopamine D2 receptor gene and alcoholism. JAMA. 264:1990;3156-3160.
25. Gelernter J, O'Malley S, Risch N, Kranzler HR, Krystal J, Merikangas K, Kennedy JL, Kidd KK. No association between an allele at the D2 dopamine receptor gene (DRD2) and alcoholism. JAMA. 266:1991;1801-1807.
26. Turner E, Ewing J, Shilling P, Smith TL, Irwin M, Schuckit M, Kelso JR. Lack of association between an RFLP near the D2 dopamine receptor gene and severe alcoholism. Biol Psychiatry. 31:1992;285-290.
27. Cook BL, Wang ZW, Crowe RR, Hauser R, Freimer M. Alcoholism and the D2 receptor gene. Alcohol Clin Exp Res. 16:1992;806-809.
28. Geijer T, Neiman J, Rydberg U, Gyllander A, Jonsson E, Sedvall G, Valverius P, Terenius L. Dopamine D2-receptor gene polymorphisms in Scandinavian chronic alcoholics. Eur Arch Psychiatry Clin Neurosci. 244:1994;26-32.
29. Conneally PM. Association between the D2 dopamine receptor gene and alcoholism. Arch Gen Psychiatry. 48:1991;664-666.
30. Pato CN, Macciardi F, Pato MT, Verga M, Kennedy JL. Review of the putative association of dopamine D2 receptor and alcoholism: a meta-analysis. Neuropsychiatr Gen. 48:1993;78-82.
31. Gelernter J, Goldman D, Risch N. The A1 allele at the D2 dopamine receptor gene and alcoholism: a reappraisal. JAMA. 269:1993;1673-1677.
32. Uhl G, Blum K, Noble E, Smith S. Substance abuse vulnerability and D2 receptor genes. Trends Neurosci. 16:1993;83-88.
33. Smith SS, O'Hara BF, Persico AM, Gorelick DA, Newlin DB, Vlahov D, Solomon L, Pickens R, Uhl GR. The D2 dopamine receptor Taq 1 B1 restriction fragment length polymorphism appears more frequently in polysubstance abusers. Arch Gen Psychiatry. 49:1992;723-727.
34. O'Hara BF, Smith SS, Bird G, Persico AM, Suarez BK, Cutting GR, Uhl GR. Dopamine D2 receptor RFLPs, haplotypes and their association with substance use in black and caucasian research volunteers. Hum Hered. 43:1993;209-218.
35. Noble EP, Blum K, Khalsa ME, Ritchie T, Montgomery A, Wood R, Fitch RJ, Ozkaragoz T, Sheridan PJ, Anglin MD, et al. Allelic association of D2 dopamine receptor gene with cocaine dependence. Drug Alc Depend. 33:1993;271-285.
36. Noble EP, Jeor STS, Ritchie T, Syndulko K, Jeor SCS, Fitch RJ, Brunner RL, Sparkes RS. D2 dopamine receptor gene and cigarette smoking: a reward gene? Med Hypotheses. 42:1994;257-260.
37. Comings DE, MacMurray J, Johnson P, Dietz G, Muhleman D. Dopamine D2 receptor gene (DRD2) haplotypes and the defense style questionnaire in substance abuse, Tourette syndrome, and controls. Biol Psych. 37:1995;798-805.
38. Peroutka SJ, Wilhoit T, Jones K. Clinical susceptibility to migraine with aura is modified by dopamine D2 receptor (DRD2) Ncol alleles. Neurology. 49:1997;201-206.